Completed OBSERVATIONAL NCT01336777

Regional Fat Depots and Insulin Resistance

Heterogeneity of Fat Depots

Sponsor: National Institutes of Health (NIH)

Conditions Diabetes Mellitus Type 2 Insulin Resistance Obesity

Updated 11 times since 2017 Last updated: Dec 2, 2024 Started: Aug 31, 2009 Primary completion: May 31, 2013 Completion: May 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes Mellitus Type 2 and Insulin Resistance, this trial is completed. The trial is conducted by National Institutes of Health (NIH) and has accumulated 11 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

11 versions recorded

Jan 2025 — Present [monthly]

Completed

Status: Unknown → Completed
Sep 2024 — Jan 2025 [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Unknown Status
Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Aug 2017 [monthly]

Unknown Status NA

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institutes of Health (NIH)
Stanford University
University of California

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States